Implantable pacemaker

• US 8,452,397 B2
• Filed: 03/30/2007
• Issued: 05/28/2013
• Est. Priority Date: 03/31/2006
• Status: Active Grant

• Current Assignee: Siemens Healthcare GMBH (Siemens AG)
• Original Assignee: Siemens AG
• Inventors: Maschke, Michael
• Primary Examiner(s): Bertram, Eric D.
• Assistant Examiner(s): Dinga, Roland
• Application Number:
  US11/731,895
• Publication Number:
  US 20070233200A1
• Time in Patent Office: 2,251 Days
• Field of Search: 607/9, 607/27, 607/36, 607/63
• US Class Current: 607/9
• CPC Class Codes: A61N 1/37 Monitoring; Protecting
• CPC Class Codes: A61N 1/37512 Pacemakers
• CPC Class Codes: B82Y 30/00 Nanotechnology for materials or surface science, e.g. nanocomposites

Abstract

A pacemaker comprises an implantable pacemaker housing and a pacemaker electrode which is provided for the transmission of stimulation pulses. A switching element, in particular a reversibly actuatable switching element, is provided for interrupting, reducing or limiting a current flowing through the pacemaker electrode, said current being inducible by an external magnetic field. Parts of the pacemaker are coated with a material, in particular a nanostructured material, which counteracts magnetic effects.

Claims

1. A pacemaker used by a patient, comprising:

an implantable pacemaker housing;

a pulse generator arranged in the pacemaker housing that generates a stimulation pulse;

a pacemaker electrode that transmits the stimulation pulse to a heart of the patient;

a switching element that regulates a current flowing through the pacemaker electrode to the heart of the patient, the current being induced by an external magnetic field;

a telemetry unit that switches the switching element; and

an identification unit arranged inside the pacemaker electrode,

wherein the identification unit is a radio frequency identification chip,

wherein a stimulation threshold of the pacemaker is not affected by the external magnetic field when the pacemaker is active if the external magnetic field does not exceed an admissible threshold value,

wherein the pacemaker comprises a magnetically actuatable fixing element for fixing the pacemaker electrode,

wherein the switching element is reversibly actuatable for renewed activation of the pacemaker after a preceding shutdown,

wherein the stimulation threshold of the pacemaker changes over time as a result of tissue fibrosis in a tip of the pacemaker electrode that may lead the pacemaker to no longer function,

wherein the tip of the pacemaker electrode comprises a plurality of recesses for holding an active substance, and

wherein the tissue fibrosis is prevented by a long-lasting release of the active substance from the tip of the pacemaker electrode so that the stimulation threshold of the pacemaker is not increased significantly.

2. The pacemaker as claimed in claim 1, wherein the switching element interrupts, reduces, or limits the current flowing through the pacemaker electrode.

3. The pacemaker as claimed in claim 1, wherein the external magnetic field is generated by a medical instrument during a medical examination of the patient.

4. The pacemaker as claimed in claim 1,

wherein the switching element is a semiconductor switching element, and

wherein the semiconductor switching element is integrated in a circuit.

5. The pacemaker as claimed in claim 1, wherein the switching element comprises a Zener diode or two Zener diodes connected back to back.

6. The pacemaker as claimed in claim 1, wherein the switching element is switched depending on a strength of the external magnetic field.

7. The pacemaker as claimed in claim 1, wherein the switching element comprises a non-ferromagnetic metal component.

8. The pacemaker as claimed in claim 1,

further comprising a magnet arranged on the pacemaker electrode for navigating the pacemaker electrode in the external magnetic field, and

wherein the magnet is an electromagnet or a permanent magnet.

9. The pacemaker as claimed in claim 1,

wherein a part of the pacemaker is coated with a material to counteract a magnetic effect of the external magnetic field,

wherein the coated part of the pacemaker is the pacemaker housing or the pacemaker electrode, and

wherein the material comprises a nanostructured material.

10. The pacemaker as claimed in claim 1, further comprising a low-pass filter arranged between an anode and a cathode of the pacemaker electrode.

11. The pacemaker as claimed in claim 1, wherein the pacemaker electrode comprises an ultrasound measurement element or an optical coherence tomography measurement element.

12. The pacemaker as claimed in claim 1, wherein the switching element is switched depending on a temperature of the pacemaker electrode.

13. The pacemaker as claimed in claim 1, wherein the recesses are sealed wells arranged on a surface of the tip of the pacemaker electrode.

14. The pacemaker as claimed in claim 1, wherein the recesses are sealed with a material that can be degraded as a function of temperature.

15. A method for protecting a patient carrying a pacemaker in a medical examination, comprising:

connecting a switching element to a pacemaker electrode;

operating the switching element to regulate a current flowing through the pacemaker electrode to a heart of the patient, the current being induced by an external magnetic field generated by a medical instrument during the medical examination;

switching the switching element via a telemetry unit; and

arranging an identification unit inside the pacemaker electrode,

wherein the identification unit is a radio frequency identification chip,

wherein a stimulation threshold of the pacemaker is not affected by the external magnetic field when the pacemaker is active if the external magnetic field does not exceed an admissible threshold value,

wherein the pacemaker comprises a magnetically actuatable fixing element for fixing the pacemaker electrode,

wherein the switching element is reversibly actuatable for renewed activation of the pacemaker after a preceding shutdown,

wherein the stimulation threshold of the pacemaker changes over time as a result of tissue fibrosis in a tip of the pacemaker electrode that may lead the pacemaker to no longer function,

wherein the tip of the pacemaker electrode comprises a plurality of recesses for holding an active substance, and

wherein the tissue fibrosis is prevented by a long-lasting release of the active substance from the tip of the pacemaker electrode so that the stimulation threshold of the pacemaker is not increased significantly.

16. The method as claimed in the claim 15, wherein the switching element interrupts, reduces, or limits the current flowing through the pacemaker electrode.